A Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Claritin® Tablets 24-Hour in Subjects With Allergic Conjunctivitis
Clinical trial NCT05265910 · COMPLETED
Trial details
- NCT number
- NCT05265910
- Sponsor
- Andover Research Eye Institute
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-14
- Primary completion
- 2022-04-23
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.